High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00517
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2018
Authors
Publisher
Frontiers Media SA